PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.). (Q39440275)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.). (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

Atlantic salmon

0 references

0 references

author name string

Børge N Fredriksen

1

1 reference

Europe PubMed Central

12 September 2017

Jostein Grip

2

1 reference

Europe PubMed Central

12 September 2017

language of work or name

0 references

publication date

18 November 2011

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

30

1 reference

Europe PubMed Central

12 September 2017

3

1 reference

Europe PubMed Central

12 September 2017

656-667

1 reference

Europe PubMed Central

12 September 2017

The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

A comparative immunopathological study of injection site reactions in salmonids following intraperitoneal injection with oil-adjuvanted vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Memory antibody response from antigen loaded polymer particles and the effect of antigen release kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Correlation between in vitro release and in vivo immune response from biodegradable polymer particles entrapping tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Early immune responses in Atlantic salmon (Salmo salar L.) after immunization with PLGA nanoparticles loaded with a model antigen and β-glucan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

The preparation and characterization of a radioiodinated bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

A highly phagocytic cell line TO from Atlantic salmon is CD83 positive and M-CSFR negative, indicating a dendritic-like cell type

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

A salmonid cell line (TO) for production of infectious salmon anaemia virus (ISAV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Size effect on the antibody production induced by biodegradable microspheres containing antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Melano‐macrophage centres and their role in fish pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.10.105

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39440275&oldid=1458796709"